Alafair's product is designed to provide a conformable, bioresorbable, and tissue-adherent matrix to allow gliding and limit post-op soft tissue tethering.
Designed for use with 28mm femoral heads, the system delivers a reproducible solution for fracture management, osteonecrosis, and revision hip applications.
The company received FDA clearance to market knotless, tape-loaded anchors designed for ligament augmentation in the foot, ankle, knee, shoulder, and hip.
The first milestone of this agreement focuses on clinical research aimed at achieving European regulatory compliance for a surgeon-supervised robot designed for spine surgery.